These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 3079654

  • 1. Serum bone GLA-protein is not a sensitive marker of bone turnover in Paget's disease of bone.
    Delmas PD, Demiaux B, Malaval L, Chapuy MC, Meunier PJ.
    Calcif Tissue Int; 1986 Jan; 38(1):60-1. PubMed ID: 3079654
    [Abstract] [Full Text] [Related]

  • 2. Osteocalcin and bone remodelling in Paget's disease of bone, primary hyperparathyroidism, hypercalcaemia of malignancy and involutional osteoporosis.
    Torres R, de la Piedra C, Rapado A.
    Scand J Clin Lab Invest; 1989 May; 49(3):279-85. PubMed ID: 2787049
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Correlation between serum osteocalcin and 24,25-dihydroxyvitamin D levels in Paget's disease of bone.
    Castro-Errecaborde N, de la Piedra C, Rapado A, Alvarez-Arroyo MV, Torres R, Traba ML.
    J Clin Endocrinol Metab; 1991 Feb; 72(2):462-6. PubMed ID: 1991815
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Urinary gamma-carboxyglutamic acid and serum osteocalcin as bone markers: studies in osteoporosis and Paget's disease.
    Gundberg CM, Lian JB, Gallop PM, Steinberg JJ.
    J Clin Endocrinol Metab; 1983 Dec; 57(6):1221-5. PubMed ID: 6605357
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Serum osteocalcin in Paget's disease of bone: basal concentrations and response to bisphosphonate treatment.
    Papapoulos SE, Frolich M, Mudde AH, Harinck HI, vd Berg H, Bijvoet OL.
    J Clin Endocrinol Metab; 1987 Jul; 65(1):89-94. PubMed ID: 3495547
    [Abstract] [Full Text] [Related]

  • 11. [Skeletal distribution and biological markers of Paget's disease].
    Meunier PJ, Salson C, Delmas PD.
    Rev Prat; 1989 Apr 27; 39(13):1125-8. PubMed ID: 2786643
    [Abstract] [Full Text] [Related]

  • 12. Biochemical markers of bone turnover in Paget's disease.
    Russell RG, Beard DJ, Cameron EC, Douglas DL, Forrest AR, Guilland-Cumming D, Paterson AD, Poser J, Preston CJ, Milford-Ward A, Woodhead S, Kanis JA.
    Metab Bone Dis Relat Res; 1981 Apr 27; 3(4-5):255-62. PubMed ID: 6220191
    [Abstract] [Full Text] [Related]

  • 13. Biochemical markers of bone turnover in Paget's disease of bone.
    Eastell R.
    Bone; 1999 May 27; 24(5 Suppl):49S-50S. PubMed ID: 10321928
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Quantitative evaluation of bone scintigraphy in the assessment of Paget's disease activity.
    Pons F, Alvarez L, Peris P, Guañabens N, Vidal-Sicart S, Monegal A, Pavía J, Ballesta AM, Muños-Gómez J, Herranz R.
    Nucl Med Commun; 1999 Jun 27; 20(6):525-8. PubMed ID: 10451864
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effects of two different bisphosphonates on Paget's disease of bone: ICTP assessed.
    Filipponi P, Pedetti M, Beghe F, Giovagnini B, Miam M, Cristallini S.
    Bone; 1994 Jun 27; 15(3):261-7. PubMed ID: 8068446
    [Abstract] [Full Text] [Related]

  • 20. Normal carboxylation of circulating osteocalcin (bone Gla-protein) in Paget's disease of bone.
    Merle B, Delmas PD.
    Bone Miner; 1990 Nov 27; 11(2):237-45. PubMed ID: 2176559
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.